IMS2186
SIGMA/I7160 - ≥98% (HPLC), solid
Synonym: 3-
CAS Number: 1031206-36-6
Empirical Formula (Hill Notation): C18H16O4
Molecular Weight: 296.32
MDL Number: MFCD12912419
Linear Formula: C18H16O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | solid |
| InChI | 1S/C18H16O4/c1-11-3-5-16- |
| InChI key | BZCADTHMZLYKAR-MDWZMJQESA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(cc1O)C=C2/COc3cc |
| solubility | DMSO: >20 mg/mL |
| storage condition | desiccated |
| storage temp. | room temp |
| Biochem/physiol Actions: | IMS2186 is an anti-proliferative and anti-angiogenic agent. Apparently IMS2186 blocks the cell cycle at G2 and inhibits the production of PGE2/TNF-α. IMS2186 inhibits cell growth in vitro in tumor cells, non-transformed fibroblasts, and retinal pigment epithelial cells. IMS2186 inhibits angiogenesis (IC50 = 0.1 μM) and cell migration. Intraocular injection of IMS2186 could be a long-lasting effective treatment for CNV (choroidal neovascularization) in AMD (age-related macular degeneration) with a reduction in scarring and related visual loss. |
| Biochem/physiol Actions: | IMS2186 is an anti-proliferative and anti-angiogenic. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H400 |
| Precautionary statements | P273 |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


